Header Logo

Connection

Andrew Karter to Hypertension

This is a "connection" page, showing publications Andrew Karter has written about Hypertension.
Connection Strength

0.217
  1. New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. Health Serv Res. 2009 Oct; 44(5 Pt 1):1640-61.
    View in: PubMed
    Score: 0.059
  2. Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med. 2006 Apr 04; 144(7):475-84.
    View in: PubMed
    Score: 0.048
  3. High rates of co-occurrence of hypertension, elevated low-density lipoprotein cholesterol, and diabetes mellitus in a large managed care population. Am J Manag Care. 2004 Feb; 10(2 Pt 2):163-70.
    View in: PubMed
    Score: 0.041
  4. Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis. Diabetes Care. 2015 May; 38(5):905-12.
    View in: PubMed
    Score: 0.022
  5. Treatment intensification and risk factor control: toward more clinically relevant quality measures. Med Care. 2009 Apr; 47(4):395-402.
    View in: PubMed
    Score: 0.015
  6. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med. 2008 May; 23(5):588-94.
    View in: PubMed
    Score: 0.014
  7. Diabetes and progression of carotid atherosclerosis: the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol. 2003 Jun 01; 23(6):1035-41.
    View in: PubMed
    Score: 0.010
  8. Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study. Diabetes. 2002 Aug; 51(8):2642-7.
    View in: PubMed
    Score: 0.009

© 2024 Kaiser Permanente